InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-43.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Holmlin R. Erik, 董事长兼首席执行官. Officer active across 3 companies, notably Bionano Genomics, Inc. In total, 12 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €17k. History available since 12 May 2021. The latest transaction was filed on 17 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Holmlin R. Erik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
51 股@ US$1.100.0% 占其流量Common StockSEC:0001579988-26-000004:0
75 股@ US$3.690.2% 占其流量Common StockSEC:0001411690-25-000053:0
198 股@ US$3.470.5% 占其流量Common StockSEC:0001411690-25-000028:0
51 股@ US$5.730.2% 占其流量Common StockSEC:0001411690-25-000017:0
44,000 股0Common StockSEC:0001415889-24-015621:0
3,073 股@ US$1.272.9% 占其流量Common StockSEC:0001415889-24-006809:0
15,000 股@ US$0.64267.0% 占其流量Common StockSEC:0001411690-23-000032:0
标准退出：2023年8月14日 (T+90)
50,141 股@ US$0.6623.8% 占其流量Common StockSEC:0001411690-23-000029:0
300,000 股0Common StockSEC:0001209191-23-010921:0
50,141 股@ US$1.410.41% mcap81.4% 占其流量Common StockSEC:0001209191-22-029457:0
2,200 股@ US$3.9856.5% 占其流量Common StockSEC:0001209191-21-067229:0
标准退出：2022年2月27日 (T+90)
290,000 股0Common StockSEC:0001209191-21-032934:0
12 条申报中的 12 条
About Holmlin R. Erik
R. Erik Holmlin is President and CEO of Bionano Genomics, Inc. He is responsible for the strategic and operational leadership of the company, overseeing all activities to ensure growth and innovation. With extensive experience in the biotechnology sector, he plays a key role in shaping the company's vision and objectives. His leadership is essential for navigating a competitive environment.
